Request Legal Help Now - Free


FDA Requires Blood Clot Warning on Testosterone Products

. By
Washington, DCIn public announcement issued this week, the US Food and Drug Administration (FDA) states it is requiring manufacturers to include a general warning in the drug labeling of all testosterone products about the risk of blood clots in the veins. The labeling change results from postmarket reports of venous blood clots unrelated to polycythemia. The change will be required to drug labeling of all testosterone products to provide a more general warning regarding venous blood clots and to ensure this risk is described consistently in the labeling of all approved testosterone products.

Blood clots in the veins, also known as venous thromboembolism (VTE), include deep vein thrombosis (DVT) and pulmonary embolism (PE). The risk of venous blood clots is already included in the labeling of testosterone products as a possible consequence of polycythemia, an abnormal increase in the number of red blood cells that sometimes occurs with testosterone treatment. Because these clots occur in the veins, this new warning is not related to FDA’s ongoing evaluation of the possible risk of stroke, heart attack, and death in patients taking testosterone products. We are currently evaluating the potential risk of these cardiovascular events, which are related to blood clots in the arteries and are described in the Drug Safety Communication posted on January 31, 2014.

Testosterone products are FDA-approved for use in men who lack or have low testosterone levels in conjunction with an associated medical condition. Examples of these conditions include failure of the testicles to produce testosterone for reasons such as genetic problems or chemotherapy.


Testosterone Legal Help

If you or a loved one have suffered losses in this case, please click the link below and your complaint will be sent to a drugs & medical lawyer who may evaluate your claim at no cost or obligation.


Posted by

There are many medications that can potentially cause Thrombus including Birth Control Pills, just to mention just one of many common meds. However, as a Physician, we take all precautions including screening prior and during a patient taking the medication. Obviously, Risks Vs Benefit must be taken into account but to deny a patient suffering from Low Testosterone due Prostate cancer treatment to genetic causes can cause severe depression, total lack of sexual drive or performance, breast and other female like physical changes, etc., yet there are medications that can be implemented and monitored to prevent Thrombus due Platelet increase. I hope FDA take's all of these factor's very seriously.


Fields marked * are mandatory. Please read our comment guidelines before posting.


Note: Your name will be published with your comment.

*Email Address:

Your email will only be used if a response is needed.
*Your Comment:

Are you the defendant or a subject matter expert on this topic with an opposing viewpoint? We'd love to hear your comments here as well, or if you'd like to contact us for an interview please submit your details here.

Click to learn more about

Request Legal Help Now! - Free